Mettler-Toledo International, Inc. $MTD Shares Bought by Shell Asset Management Co.

Shell Asset Management Co. lifted its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 120.7% in the second quarter, Holdings Channel reports. The institutional investor owned 1,309 shares of the medical instruments supplier’s stock after acquiring an additional 716 shares during the quarter. Shell Asset Management Co.’s holdings in Mettler-Toledo International were worth $1,538,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Mettler-Toledo International by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier’s stock worth $3,003,485,000 after buying an additional 30,535 shares during the last quarter. Alliancebernstein L.P. increased its holdings in shares of Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after buying an additional 126,147 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Mettler-Toledo International by 5.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock worth $568,032,000 after buying an additional 25,272 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in shares of Mettler-Toledo International by 11.9% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier’s stock worth $479,673,000 after buying an additional 43,082 shares during the last quarter. Finally, PineStone Asset Management Inc. increased its holdings in shares of Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock worth $392,766,000 after buying an additional 98,737 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Activity

In other news, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the sale, the director directly owned 283 shares in the company, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the sale, the chief financial officer owned 5,095 shares in the company, valued at $6,750,875. The trade was a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,827 shares of company stock worth $2,371,208. 1.94% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on MTD shares. Weiss Ratings restated a “hold (c)” rating on shares of Mettler-Toledo International in a report on Wednesday. Robert W. Baird increased their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Evercore ISI increased their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday. Barclays increased their price objective on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an “overweight” rating in a research report on Thursday, October 2nd. Finally, Bank of America increased their price objective on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research report on Monday, September 22nd. Five equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $1,342.22.

Mettler-Toledo International Stock Up 1.5%

Shares of MTD stock opened at $1,328.52 on Thursday. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,486.76. The stock has a market capitalization of $27.37 billion, a PE ratio of 33.64, a P/E/G ratio of 3.93 and a beta of 1.37. The firm has a 50 day moving average of $1,276.00 and a two-hundred day moving average of $1,188.84.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $983.22 million during the quarter, compared to analysts’ expectations of $957.41 million. During the same quarter last year, the company posted $9.65 EPS. The firm’s revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.